48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Does Bone Resorption Stimulate Periosteal Expansion? A Cross‐Sectional Analysis of β‐C‐telopeptides of Type I Collagen (CTX), Genetic Markers of the RANKL Pathway, and Periosteal Circumference as Measured by pQCT

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          We hypothesized that bone resorption acts to increase bone strength through stimulation of periosteal expansion. Hence, we examined whether bone resorption, as reflected by serum β‐C‐telopeptides of type I collagen (CTX), is positively associated with periosteal circumference (PC), in contrast to inverse associations with parameters related to bone remodeling such as cortical bone mineral density (BMD C). CTX and mid‐tibial peripheral quantitative computed tomography (pQCT) scans were available in 1130 adolescents (mean age 15.5 years) from the Avon Longitudinal Study of Parents and Children (ALSPAC). Analyses were adjusted for age, gender, time of sampling, tanner stage, lean mass, fat mass, and height. CTX was positively related to PC ( β = 0.19 [0.13, 0.24]) (coefficient = SD change per SD increase in CTX, 95% confidence interval)] but inversely associated with BMD C ( β = –0.46 [–0.52,–0.40]) and cortical thickness [ β = –0.11 (–0.18, –0.03)]. CTX was positively related to bone strength as reflected by the strength‐strain index (SSI) ( β = 0.09 [0.03, 0.14]). To examine the causal nature of this relationship, we then analyzed whether single‐nucleotide polymorphisms (SNPs) within key osteoclast regulatory genes, known to reduce areal/cortical BMD, conversely increase PC. Fifteen such genetic variants within or proximal to genes encoding receptor activator of NF‐κB (RANK), RANK ligand (RANKL), and osteoprotegerin (OPG) were identified by literature search. Six of the 15 alleles that were inversely related to BMD were positively related to CTX ( p < 0.05 cut‐off) ( n = 2379). Subsequently, we performed a meta‐analysis of associations between these SNPs and PC in ALSPAC ( n = 3382), Gothenburg Osteoporosis and Obesity Determinants (GOOD) ( n = 938), and the Young Finns Study (YFS) ( n = 1558). Five of the 15 alleles that were inversely related to BMD were positively related to PC ( p < 0.05 cut‐off). We conclude that despite having lower BMD, individuals with a genetic predisposition to higher bone resorption have greater bone size, suggesting that higher bone resorption is permissive for greater periosteal expansion. © 2014 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?

          Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization-the random assortment of genes from parents to offspring that occurs during gamete formation and conception-provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization-the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bone "mass" and the "mechanostat": a proposal.

            H. Frost (1987)
            The observed fit of bone mass to a healthy animal's typical mechanical usage indicates some mechanism or mechanisms monitor that usage and control the three longitudinal growth, bone modeling, and BMU-based remodeling activities that directly determine bone mass. That mechanism could be named a mechanostat. Accumulated evidence suggests it includes the bone itself, plus mechanisms that transform its mechanical usage into appropriate signals, plus other mechanisms that detect those signals and then direct the above three biologic activities. In vivo studies have shown that bone strains in or above the 1500-3000 microstrain range cause bone modelling to increase cortical bone mass, while strains below the 100-300 microstrain range release BMU-based remodeling which then removes existing cortical-endosteal and trabecular bone. That arrangement provides a dual system in which bone modeling would adapt bone mass to gross overloading, while BMU-based remodeling would adapt bone mass to gross underloading, and the above strain ranges would be the approximate "setpoints" of those responses. The anatomical distribution of those mechanical usage effects are well known. If circulating agents or disease changed the effective setpoints of those responses their bone mass effects should copy the anatomical distribution of the mechanical usage effects. That seems to be the case for many agents and diseases, and several examples are discussed, including postmenopausal osteoporosis, fluoride effects, bone loss in orbit, and osteogenesis imperfecta. The mechanostat proposal is a seminal idea which fits diverse evidence but it requires critique and experimental study.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice.

              The osteoblast-specific secreted molecule osteocalcin behaves as a hormone regulating glucose metabolism and fat mass in two mutant mouse strains. Here, we ask two questions: is the action of osteocalcin on beta cells and adipocytes elicited by the same concentrations of the molecule, and more importantly, does osteocalcin regulate energy metabolism in WT mice? Cell-based assays using isolated pancreatic islets, a beta cell line, and primary adipocytes showed that picomolar amounts of osteocalcin are sufficient to regulate the expression of the insulin genes and beta cell proliferation markers, whereas nanomolar amounts affect adiponectin and Pgc1alpha expression in white and brown adipocytes, respectively. In vivo the same difference exists in osteocalcin's ability to regulate glucose metabolism on the one hand and affect insulin sensitivity and fat mass on the other hand. Furthermore, we show that long-term treatment of WT mice with osteocalcin can significantly weaken the deleterious effect on body mass and glucose metabolism of gold thioglucose-induced hyperphagia and high-fat diet. These results establish in WT mice the importance of this novel molecular player in the regulation of glucose metabolism and fat mass and suggest that osteocalcin may be of value in the treatment of metabolic diseases.
                Bookmark

                Author and article information

                Journal
                J Bone Miner Res
                J. Bone Miner. Res
                10.1002/(ISSN)1523-4681
                JBMR
                Journal of Bone and Mineral Research
                American Society for Bone and Mineral Research
                0884-0431
                1523-4681
                19 March 2014
                19 March 2014
                : 29
                : 4 ( doiID: 10.1002/jbmr.v29.4 )
                : 1015-1024
                Affiliations
                [ 1 ] MRC Centre for Causal Analyses in Translational EpidemiologyUniversity of Bristol BristolUK
                [ 2 ] School of Social and Community MedicineUniversity of Bristol BristolUK
                [ 3 ] Center for Bone and Arthritis ResearchInstitute of Medicine, Sahlgrenska Academy, University of Gothenburg GothenburgSweden
                [ 4 ] Geriatric Medicine, Department of Internal Medicine and Clinical NutritionUniversity of Gothenburg GothenburgSweden
                [ 5 ] Department of Clinical Chemistry, Fimlab Laboratoriesand University of Tampere School of Medicine TampereFinland
                [ 6 ] Department of Clinical PhysiologyUniversity of Tampere School of Medicine and Tampere University Hospital TampereFinland
                [ 7 ] Research Centre of Applied and Preventive Cardiovascular Medicine University of Turku and the Department of Clinical Physiology and Nuclear MedicineTurku University Hospital TurkuFinland
                [ 8 ] Department of Food and Environmental SciencesUniversity of Helsinki HelsinkiFinland
                [ 9 ] The UKK Institute for Health Promotion ResearchTampere Finland
                [ 10 ] Department of MedicineUniversity of Turku and Turku University Hospital TurkuFinland
                [ 11 ] Norwich Medical SchoolUniversity of East Anglia East AngliaUK
                [ 12 ] School of Clinical SciencesUniversity of Bristol BristolUK
                Author notes
                [*] [* ]Address correspondence to: Jon Tobias, MD, PhD, Musculoskeletal Research Unit, Avon Orthopaedic Centre, Southmead Hospital, Bristol BS10 5NB, United Kingdom. E‐mail: Jon.Tobias@ 123456bristol.ac.uk
                Article
                JBMR2093
                10.1002/jbmr.2093
                4138988
                24014423
                172c1733-2703-4373-8519-ccca753155ee
                © 2014 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals, Inc. on behalf of the American Society for Bone and Mineral Research

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 16 June 2013
                : 30 August 2013
                : 03 September 2013
                Page count
                Pages: 10
                Funding
                Funded by: Wellcome Trust
                Award ID: 084632
                Funded by: Wellcome Trust grant
                Award ID: 079960
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                jbmr2093
                April 2014
                Converter:WILEY_ML3GV2_TO_NLM version:4.0.7 mode:remove_FC converted:25.07.2014

                Human biology
                ctx,bone resorption,periosteal expansion,pqct
                Human biology
                ctx, bone resorption, periosteal expansion, pqct

                Comments

                Comment on this article